These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18834687)

  • 1. Small nodules (1-2 cm) in liver cirrhosis: characterization with contrast-enhanced ultrasound.
    Jang HJ; Kim TK; Wilson SR
    Eur J Radiol; 2009 Dec; 72(3):418-24. PubMed ID: 18834687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
    Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
    Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced ultrasound in the diagnosis of nodules in liver cirrhosis.
    Kim TK; Jang HJ
    World J Gastroenterol; 2014 Apr; 20(13):3590-6. PubMed ID: 24707142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
    Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
    Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound.
    Kim TK; Lee KH; Khalili K; Jang HJ
    Abdom Imaging; 2011 Jun; 36(3):244-63. PubMed ID: 21253723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of regenerative nodule, dysplastic nodule, and small hepatocellular carcinoma in cirrhotic patients: a contrast-enhanced ultrasound-based multivariable model analysis.
    Duan Y; Xie X; Li Q; Mercaldo N; Samir AE; Kuang M; Lin M
    Eur Radiol; 2020 Sep; 30(9):4741-4751. PubMed ID: 32307563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2 cm.
    Forner A; Vilana R; Bianchi L; Rodríguez-Lope C; Reig M; García-Criado MÁ; Rimola J; Solé M; Ayuso C; Bru C; Bruix J
    J Hepatol; 2015 Jan; 62(1):150-5. PubMed ID: 25173969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small hepatic nodules (< or =2 cm) in cirrhosis patients: characterization with contrast-enhanced ultrasonography.
    Wang JH; Lu SN; Hung CH; Chen TY; Chen CH; Changchien CS; Lee CM
    Liver Int; 2006 Oct; 26(8):928-34. PubMed ID: 16953832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
    Huang JY; Li JW; Lu Q; Luo Y; Lin L; Shi YJ; Li T; Liu JB; Lyshchik A
    Radiology; 2020 Feb; 294(2):329-339. PubMed ID: 31793849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
    Forner A; Vilana R; Ayuso C; Bianchi L; Solé M; Ayuso JR; Boix L; Sala M; Varela M; Llovet JM; Brú C; Bruix J
    Hepatology; 2008 Jan; 47(1):97-104. PubMed ID: 18069697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
    Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
    Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-Enhanced Ultrasound: a Simple and Effective Tool in Defining a Rapid Diagnostic Work-up for Small Nodules Detected in Cirrhotic Patients during Surveillance.
    Giorgio A; Montesarchio L; Gatti P; Amendola F; Matteucci P; Santoro B; Merola MG; Merola F; Coppola C; Giorgio V
    J Gastrointestin Liver Dis; 2016 Jun; 25(2):205-11. PubMed ID: 27308652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver disease.
    Numata K; Fukuda H; Nihonmatsu H; Kondo M; Nozaki A; Chuma M; Morimoto M; Oshima T; Okada M; Murakami T; Takebayashi S; Maeda S; Inayama Y; Nakano M; Tanaka K
    Abdom Imaging; 2015 Oct; 40(7):2372-83. PubMed ID: 26099473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study.
    Strobel D; Jung EM; Ziesch M; Praktiknjo M; Link A; Dietrich CF; Klinger C; Schultheiß M; Jesper D; Schellhaas B
    Eur Radiol; 2021 Oct; 31(10):7614-7625. PubMed ID: 33855588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis.
    Vidili G; Arru M; Solinas G; Calvisi DF; Meloni P; Sauchella A; Turilli D; Fabio C; Cossu A; Madeddu G; Babudieri S; Zocco MA; Iannetti G; Di Lembo E; Delitala AP; Manetti R
    World J Gastroenterol; 2022 Jul; 28(27):3488-3502. PubMed ID: 36158272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEUS: An essential component in a multimodality approach to small nodules in patients at high-risk for hepatocellular carcinoma.
    Jang HJ; Kim TK; Burns PN; Wilson SR
    Eur J Radiol; 2015 Sep; 84(9):1623-35. PubMed ID: 26092406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrimination between neoplastic and non-neoplastic lesions in cirrhotic liver using contrast-enhanced ultrasound.
    Xu HX; Lu MD; Liu LN; Zhang YF; Guo LH; Xu JM; Liu C
    Br J Radiol; 2012 Oct; 85(1018):1376-84. PubMed ID: 22553290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of contrast-enhanced ultrasound for diagnosis of dysplastic nodules with a focus of hepatocellular carcinoma in liver cirrhosis patients.
    Wu W; Chen M; Yan K; Dai Y; Yin S; Yang W; Fan Z
    Chin J Cancer Res; 2015 Feb; 27(1):83-9. PubMed ID: 25717230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frame-rate contrast enhanced ultrasound (HIFR-CEUS) in the characterization of small hepatic lesions in cirrhotic patients.
    Giangregorio F; Garolfi M; Mosconi E; Ricevuti L; Debellis MG; Mendozza M; Esposito C; Vigotti E; Cadei D; Abruzzese D
    J Ultrasound; 2023 Mar; 26(1):71-79. PubMed ID: 36227456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.